A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma

Related documents

• The Effect of Altering Colonic Microflora After Fiber (FOS) Consumption#1141147
• CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases#1141148
• Child's Behavior Using Single Rotary File System Versus Manual Instrumentation in Pulpectomy of Primary Molars#1141150
• A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris#1141152
• Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia.#1141154